Significant Cuts to U.S. Global Health Aid as Administration Reassesses Priorities

In a revealing spreadsheet presented to Congress, the Trump administration plans to discontinue substantial funding to Gavi and other health initiatives aimed at combating malaria, while maintaining some support for H.I.V. and tuberculosis treatments.

The Trump administration has made a startling announcement regarding its foreign aid strategy, signaling an end to significant financial backing that has historically supported international health efforts. According to a 281-page spreadsheet obtained by The Times, the administration has decided to terminate the United States' financial support for Gavi, the vaccine alliance that has provided life-saving immunizations for children in developing nations for over twenty-five years. This decision comes amid plans to cut back on funding for malaria programs—one of the leading global health threats.

While some essential assistance, including funding for H.I.V. and tuberculosis medications along with food aid for nations rife with civil strife and natural calamities, will continue, the scale of the cuts marks a dramatic shift. The spreadsheet, sent to Congress by the United States Agency for International Development (U.S.A.I.D.), serves as a stark representation of the administration’s withdrawal from a longstanding commitment to assist developing nations. The accompanying cover letter highlights a catastrophic reduction in U.S.A.I.D.'s operations, showing that only 869 of over 6,000 employees remain active as many programs face termination.

The document indicates that while 898 awards will persevere, a staggering 5,341 will not, representing a substantial decrease in U.S.A.I.D.’s annual budget. The once robust allocation of $40 billion is poised for a dramatic rethink, with only $8.3 billion of that identified as currently available for distribution, emphasizing the seismic shift in priorities for U.S. global health diplomacy.